Skip to content
phone iconPhone 855-847-3553
  • My Portal
Search
  • ENExpand
    • ES
Contact Us
Lumicera Health Services
  • PatientsExpand
    • Log In
    • Fill Your Prescription
    • Specialty Drug List
    • Our Centers of Excellence
    • FAQ
    • Medications Disposal
    • Patient Rights
    • New Patient
    • Patient Welcome Kit
    • Multimedia Center
    • The Hearts Behind Your Health
  • PrescribersExpand
    • Log In
    • Your Patient’s Care
    • Specialty Drug List
    • FAQ
    • Multimedia Center
    • Prescriber Information
    • In-Office Drug Administration
    • Our Centers of Excellence
  • ServicesExpand
    • Specialty Pharmacy
    • Our Centers of Excellence
    • Enhance Your Programs
    • Accreditation Support
    • Logistics Solutions
    • Payer Solutions
    • Multimedia Center
  • ManufacturersExpand
    • Our Strategic Alignments
    • Analytics Expertise
    • Best in Class Programs
    • Patient Assistance Program
    • Our Centers of Excellence
    • Fulfillment
    • Multimedia Center
  • Residency ProgramsExpand
    • General Info
    • About Program–PGY1
    • About Program–PGY2
    • Where Are They Now?
    • Our Preceptors
  • InfusionExpand
    • Pharmacy DDL
    • Home Infusion
    • In-Office Drug Administration
  • News and Insights
  • Contact Us
Lumicera Health Services

  • ES

My Portal

Multi Medias

Building a Successful In-house Specialty Pharmacy

Building a Successful In-house Specialty Pharmacy

In his latest article highlighted in the ACHE-WI newsletter, our Vice President of Business Development, Eric Huckins, shares actionable insights we’ve used to help health systems unlock their specialty pharmacy’s full potential.

Read More Building a Successful In-house Specialty PharmacyContinue

Op-Ed: Why Banning PBM-Owned Pharmacies Risks Patient Care

Op-Ed: Why Banning PBM-Owned Pharmacies Risks Patient Care

Arkansas’s Act 624 to ban PBMs from owning pharmacies is being framed as a win for independent pharmacies. But what happens when legislation targets ownership structure instead of business practices?

Read More Op-Ed: Why Banning PBM-Owned Pharmacies Risks Patient CareContinue

Middle-aged blonde woman holding her young African American song in a park on a fall day

Helping Human Beings: Amanda’s Story

Amanda, Manager of Experiential Learning and Chair of the accredited Oncology Center of Excellence, has been a specialty pharmacist at Lumicera since 2023. For the past two years, she has also been a caregiver for a cancer patient…her son.

Read More Helping Human Beings: Amanda’s StoryContinue

Asembia 2025 Spotlight Podcast

Asembia 2025 Spotlight Podcast

Eric Huckins, our Vice President of Business Development, sat down with Todd Eury of the Pharmacy Podcast Network during Asembia to share his insights on specialty pharmacy.

Read More Asembia 2025 Spotlight PodcastContinue

Lumicera Partners with Arthritis Foundation for Jingle in July Race

Lumicera Partners with Arthritis Foundation for Jingle in July Race

This July, Lumicera Specialty Pharmacy will be competing as a team in the Arthritis Foundation’s annual Jingle-in-July run, walk, or bike race!

Read More Lumicera Partners with Arthritis Foundation for Jingle in July RaceContinue

Ben Interviewing with Pharmacy Podcast Network

Pharmacy Podcast Network Interviews Ben Heiser

This week, our very own Dr. Ben Heiser was a guest on the Pharmacy Podcast Network! In his interview, Ben shares just how special specialty pharmacy really is—especially when it’s done right.

Read More Pharmacy Podcast Network Interviews Ben HeiserContinue

Costco Partnership

Costco Partnership

We are thrilled to announce our partnership with Costco! With this, we will be able to grow cost-plus specialty pharmacy in the marketplace, while continuing to provide unmatched patient support!

Read More Costco PartnershipContinue

Healthcare Consumer Poll Results

Healthcare Consumer Poll Results

Our recent survey highlights several important issues patients face today, including an unclear understanding of their medication costs.

Read More Healthcare Consumer Poll ResultsContinue

Stelara Biosimilar Access

Stelara Biosimilar Access

The leading cost-plus specialty pharmacy will offer direct access to ustekinumab-aekn, reducing plan sponsor costs by up to $336,000 per patient per year and generating $120 million annualized client savings

Read More Stelara Biosimilar AccessContinue

Digital Patient Engagement Case Study

Digital Patient Engagement Case Study

Digital Patient Engagement

Read More Digital Patient Engagement Case StudyContinue

Page navigation

Previous PagePrevious 1 2 3 4 Next PageNext
  • About Us
  • Accessibility
  • Careers
  • HIPAA Notice
  • Privacy
  • Partners
  • Terms and Conditions
  • Contact Us
LinkedIn
Facebook
YouTube
Lumicera Health Services
© 2026 Lumicera All Rights Reserved. | Sitemap
URAC Accredited Specialty Pharmacy Expires 04/01/2027
URAC Accredited Specialty Pharmacy Expires 10/01/2027

  • Patients
    • Log In
    • Fill Your Prescription
    • Specialty Drug List
    • Our Centers of Excellence
    • FAQ
    • Medications Disposal
    • Patient Rights
    • New Patient
    • Patient Welcome Kit
    • Multimedia Center
    • The Hearts Behind Your Health
  • Prescribers
    • Log In
    • Your Patient’s Care
    • Specialty Drug List
    • FAQ
    • Multimedia Center
    • Prescriber Information
    • In-Office Drug Administration
    • Our Centers of Excellence
  • Services
    • Specialty Pharmacy
    • Our Centers of Excellence
    • Enhance Your Programs
    • Accreditation Support
    • Logistics Solutions
    • Payer Solutions
    • Multimedia Center
  • Manufacturers
    • Our Strategic Alignments
    • Analytics Expertise
    • Best in Class Programs
    • Patient Assistance Program
    • Our Centers of Excellence
    • Fulfillment
    • Multimedia Center
  • Residency Programs
    • General Info
    • About Program–PGY1
    • About Program–PGY2
    • Where Are They Now?
    • Our Preceptors
  • Infusion
    • Pharmacy DDL
    • Home Infusion
    • In-Office Drug Administration
  • News and Insights
  • Contact Us
Search